Home > Publications database > Inflammatory potential of the diet and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. > print |
001 | 153166 | ||
005 | 20240229123040.0 | ||
024 | 7 | _ | |a 10.1002/ijc.32870 |2 doi |
024 | 7 | _ | |a pmid:31945199 |2 pmid |
024 | 7 | _ | |a 0020-7136 |2 ISSN |
024 | 7 | _ | |a 1097-0215 |2 ISSN |
024 | 7 | _ | |a altmetric:74143402 |2 altmetric |
037 | _ | _ | |a DKFZ-2020-00219 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Jakszyn, P. |0 0000-0003-0672-8847 |b 0 |
245 | _ | _ | |a Inflammatory potential of the diet and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. |
260 | _ | _ | |a Bognor Regis |c 2020 |b Wiley-Liss |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1597748268_9712 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2020 Aug 15;147(4):1027-1039 |
520 | _ | _ | |a Pro-inflammatory diets are associated with risk of developing colorectal cancer (CRC), however inconsistencies exist in subsite- and sex-specific associations. The relationship between CRC and combined lifestyle-related factors that contribute towards a low-grade inflammatory profile has not yet been explored. We examined the association between the dietary inflammatory potential and an inflammatory profile and CRC risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. This cohort included 476,160 participants followed-up of 14 years and 5,991 incident CRC cases (3,897 colon and 2,094 rectal tumours). Dietary inflammatory potential was estimated using an Inflammatory Score of the Diet (ISD). An Inflammatory Profile Score (IPS) was constructed, incorporating the ISD, physical activity level and abdominal obesity. The associations between the ISD and CRC and IPS and CRC were assessed using multivariable regression models. More pro- inflammatory diets were related to a higher CRC risk, particularly for colon cancer; Hazar Ratio (HR) for highest versus lowest ISD quartile was 1.15 (95% confidence interval (CI) 1.04-1.27) for CRC, 1.24 (95% CI 1.09-1.41) for colon cancer and 0.99 (95% CI 0.83-1.17) for rectal cancer. Associations were more pronounced in men and not significant in women. The IPS was associated with CRC risk, particularly colon cancer among men; HRs for the highest versus lowest IPS were 1.62 (95% CI 1.31- 2.01) for colon cancer overall and 2.11 (95% CI 1.50-2.97) for colon cancer in men. This study shows that more pro-inflammatory diets and a more inflammatory profile are associated with higher risk of CRC, principally colon cancer and in men. This article is protected by copyright. All rights reserved. |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Cayssials, V. |b 1 |
700 | 1 | _ | |a Buckland, G. |b 2 |
700 | 1 | _ | |a Perez-Cornago, A. |b 3 |
700 | 1 | _ | |a Weiderpass, E. |0 0000-0003-2237-0128 |b 4 |
700 | 1 | _ | |a Boeing, H. |b 5 |
700 | 1 | _ | |a Bergmann, M. M. |b 6 |
700 | 1 | _ | |a Vulcan, A. |b 7 |
700 | 1 | _ | |a Ohlsson, B. |b 8 |
700 | 1 | _ | |a Masala, G. |b 9 |
700 | 1 | _ | |a Cross, A. J. |b 10 |
700 | 1 | _ | |a Riboli, E. |b 11 |
700 | 1 | _ | |a Ricceri, F. |0 0000-0001-8749-9737 |b 12 |
700 | 1 | _ | |a Dahm, C. |b 13 |
700 | 1 | _ | |a Nyvang, D. |b 14 |
700 | 1 | _ | |a Katzke, V. A. |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 15 |u dkfz |
700 | 1 | _ | |a Kühns, T. |0 P:(DE-HGF)0 |b 16 |
700 | 1 | _ | |a Kyrø, C. |0 0000-0002-9083-8960 |b 17 |
700 | 1 | _ | |a Tjønneland, A. |b 18 |
700 | 1 | _ | |a Ward, H. A. |0 0000-0002-2721-2404 |b 19 |
700 | 1 | _ | |a Tsilidis, K. K. |0 0000-0002-8452-8472 |b 20 |
700 | 1 | _ | |a Skeie, G. |b 21 |
700 | 1 | _ | |a Sieri, S. |0 0000-0001-5201-172X |b 22 |
700 | 1 | _ | |a Sanchez, M. J. |b 23 |
700 | 1 | _ | |a Huerta, J. M. |b 24 |
700 | 1 | _ | |a Amiano, P. |b 25 |
700 | 1 | _ | |a Lasheras, C. |b 26 |
700 | 1 | _ | |a Ardanaz, E. |b 27 |
700 | 1 | _ | |a Mahamat-Saleh, Y. |b 28 |
700 | 1 | _ | |a Boutron-Ruault, M. C. |0 0000-0002-5956-5693 |b 29 |
700 | 1 | _ | |a Carbonnel, F. |b 30 |
700 | 1 | _ | |a Panico, S. |b 31 |
700 | 1 | _ | |a Peppa, E. |b 32 |
700 | 1 | _ | |a Trichopoulou, A. |b 33 |
700 | 1 | _ | |a Karakatsani, A. |b 34 |
700 | 1 | _ | |a Tumino, R. |b 35 |
700 | 1 | _ | |a Vermeulen, R. |b 36 |
700 | 1 | _ | |a Jenab, M. |b 37 |
700 | 1 | _ | |a Gunter, M. |b 38 |
700 | 1 | _ | |a Agudo, A. |b 39 |
773 | _ | _ | |a 10.1002/ijc.32870 |g p. ijc.32870 |0 PERI:(DE-600)1474822-8 |n 4 |p 1027-1039 |t International journal of cancer |v 147 |y 2020 |x 1097-0215 |
909 | C | O | |o oai:inrepo02.dkfz.de:153166 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-HGF)0 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J CANCER : 2017 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|